These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23875736)

  • 1. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis.
    Stavrakis S; Patel NH; Reynolds DW
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1402-8. PubMed ID: 23875736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
    Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
    Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
    Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is defibrillation testing still necessary? A decision analysis and Markov model.
    Gula LJ; Massel D; Krahn AD; Yee R; Skanes AC; Klein GJ
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):400-5. PubMed ID: 18298512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.
    Stefano B; Pietro RR; Maurizio G; Maurizio L; Renato M; Maurizio L; Pietro R; Alessandro P; Gianluca B; Monica M; Sergio C; Massimo S
    Am Heart J; 2011 Aug; 162(2):390-7. PubMed ID: 21835302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of treatment effectiveness of implantable cardioverter defibrillator in patients undergoing defibrillation threshold testing at the time of implantation versus no defibrillation threshold testing].
    Lelakowski J; Tomala I; Rydlewska A; Majewski J; Kuniewicz M; Małecka B
    Pol Merkur Lekarski; 2010 Sep; 29(171):153-6. PubMed ID: 20931822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with relatively high effective defibrillation threshold during cardioverter defibrillator implantation with endocardial leads.
    Rosenheck S; Sharon Z; Weiss A
    Cardiology; 2009; 112(2):107-13. PubMed ID: 18583908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Efficacy and Necessity of Routine Defibrillation Threshold Testing in Patients Undergoing Implantable Cardioverter-Defibrillator (ICD) Implantation.
    Ashino S; Nakai T; Sonoda K; Sasaki N; Kurokawa S; Ikeya Y; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A
    Int Heart J; 2015; 56(6):618-21. PubMed ID: 26549282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations.
    Stephenson EA; Cecchin F; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):69-73. PubMed ID: 15673391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator with and without defibrillation threshold testing.
    Codner P; Nevzorov R; Kusniec J; Haim M; Zabarski R; Strasberg B
    Isr Med Assoc J; 2012 Jun; 14(6):343-6. PubMed ID: 22891393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis.
    Betts TR; Sadarmin PP; Tomlinson DR; Rajappan K; Wong KC; de Bono JP; Bashir Y
    Europace; 2013 Jun; 15(6):813-9. PubMed ID: 23365069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is defibrillation testing necessary?
    Russo AM; Chung MK
    Cardiol Clin; 2014 May; 32(2):211-24. PubMed ID: 24793798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing.
    Hall B; Jeevanantham V; Levine E; Daubert J; McNitt S; Hall F; Jeevanantham V; Levine E; Daubert J; McNitt S; Hall FM; Jeevanantham V; Levine E; Daubert J; McNitt S; Morady FM; Pelosi F
    Cardiol J; 2007; 14(5):463-9. PubMed ID: 18651506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough?
    Pires LA; Johnson KM
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):140-5. PubMed ID: 16533250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
    Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.